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An increasing body of evidence emphasizes the role of tissue-resident memory T cells (TRM) in the defense against recurring
pathogens and malignant neoplasms. However, little is known with regard to the origin of these cells and their kinship to other
CD8+ T cell compartments. To address this issue, we followed the antigen-specific progeny of individual naive CD8+ T cells to
the T effector (TEFF), T circulating memory (TCIRCM), and TRM pools by lineage-tracing and single-cell transcriptome analysis.
We demonstrate that a subset of T cell clones possesses a heightened capacity to form TRM, and that enriched expression
of TRM–fate-associated genes is already apparent in the circulating TEFF offspring of such clones. In addition, we demonstrate
that the capacity to generate TRM is permanently imprinted at the clonal level, before skin entry. Collectively, these data
provide compelling evidence for early stage TRM fate decisions and the existence of committed TRM precursor cells in the
circulatory TEFF compartment.
Introduction
Upon local infection, antigen-specific naive CD8+ T cells undergo
rapid clonal expansion to generate a large pool of effector T cells
(TEFF) that are present in the circulation and at the affected
peripheral site. Following pathogen clearance, this effector cell
population contracts to form a small pool of memory T cells in
the blood and secondary lymphoid organs (circulating memory
T cells [TCIRCM]), and also at the site of pathogen entry (Steinert
et al., 2015). The latter population, commonly refered to as
tissue-resident memory T cells (TRM), has been shown to be
important for local control of reinfection in tissues such as skin,
intestine, and lung (Gebhardt et al., 2009; Masopust et al., 2010;
Ariotti et al., 2012; Turner et al., 2014; Mueller and Mackay,
2016) and can be distinguished from its circulating counter-
part by increased expression of markers such as CD103 and
CD69 (Mackay et al., 2013, Mueller and Mackay, 2016).
A number of studies have provided evidence that certain
subsets of TEFF possess an enhanced capacity to differentiate into
TRM. Specifically, TEFF located in inflamed tissues that express
CD69, CD103, or CD127, but lack killer cell lectin-like receptor G1
(KLRG1) expression, are considered to have a superior capacity
to give rise to TRM (Sheridan et al., 2014; Mackay et al., 2013;
Herndler-Brandstetter et al., 2018). Furthermore, those TEFF in
peripheral tissues that are prone to differentiate into TRM dis-
play a unique transcriptome that differs from the transcriptional
profile associated with TCIRCM formation (Milner et al., 2017).
While these studies have established that the propensity to
generate TRM is unequally distributed over the effector pool,
prior work has also demonstrated that TRM and TCIRCM share a
common clonal origin (Gaide et al., 2015). Thus, differences in
TRM-forming capacity do not appear imprinted in naive CD8+
T cells, but a diversification in TRM generation potential is evi-
dent in the TEFF pool. A recent study has suggested that naive
T cells can be poised for a TRM fate in steady-state conditions,
through TGFβ signaling induced by migratory dendritic cells
(Mani et al., 2019). However, it has not been elucidated whether
such poising-signals result in variations in TRM generating po-
tential between individual naive clones. Furthermore, at pre-
sent, it has not been established at which point during an
antigen-specific T cell response the progeny of naive T cells
commits to the TRM lineage.
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To address these issues, we tracked the offspring of indi-
vidual naive CD8+ T cells responding to local skin vaccination by
means of genetic barcoding. Using this lineage-tracing tool, we
provide evidence that, whereas independent T cell clones pos-
sess an equal capacity to enter inflamed tissue during the ef-
fector phase, a subset of T cell clones possesses a heightened
capacity to subsequently form tissue-resident T cell memory.
Moreover, by combining lineage tracing with single-cell RNA
sequencing (scRNA-seq), we report the existence of a circulatory
TEFF subset that bears a strong transcriptional resemblance to
TRM. Importantly, individual T cell clones contribute differen-
tially to this population, and production of this TRM-poised TEFF
subset by individual T cell clones is associated with their
capacity to form TRM. Further support for the existence of a
circulating TRM precursor comes from the observation that TRM-
forming propensity is clonally acquired before tissue entry and
is fixed upon secondary antigen encounter. Jointly, these ex-
periments provide definitive evidence for the existence of a
circulating TRM precursor population that commits to the TRM-
fate before tissue entrance.
Results
Individual T cell clones contribute proportionally to the
systemic and skin TEFF response
To evaluate how individual naive T cells contribute to the TRM
lineage, and how the TRM population is developmentally related
to the systemic CD8+ T cell subsets, we set out to track the
progeny of individual naive CD8+ T cells within the TEFF, TCIRCM,
and TRM compartment in vivo by genetic barcoding. To this
purpose, we first generated a high-diversity retroviral barcode
library (BC2.0) that comprises ∼200,000 unique cellular iden-
tifiers, thereby enabling the tracking of many individual cells in
parallel. Using this BC2.0 genetic labeling system, we subse-
quently generated naive CD8+ T cells that each carry a unique
DNA barcode (Gerlach et al., 2010, 2013). Specifically, thymo-
cytes were transduced with the BC2.0 library and injected in-
trathymically into recipient mice to allow maturation into
barcode-labeled naive T cells. This experimental approach al-
lows for the genetic labeling of naturally cycling T cell pre-
cursors, thereby avoiding a requirement for in vitro activation
of naive T cells. As shown previously, barcode-labeled T cells
that are generated in this manner behave identically to unma-
nipulated naive OT-I T cells, in terms of both T cell response
kinetics and effector differentiation potential (Gerlach et al.,
2010). To be able to examine T cell fate and T cell develop-
ment into the TRM lineage without TCR affinity as a confounder
(Zehn et al., 2009), thymocytes were obtained from OT-I TCR
transgenic mice, in which all CD8+ T cells carry the OT-I TCR
specific for the OVA257–264-H2-Kb complex (Fig. 1 A).
After in vivo development of barcode-labeled thymocytes
into mature naive GFP+ OT-I T cell clones, cells were harvested,
and physiologically relevant numbers (i.e., 500–1,000; Obar
et al., 2008) of cells were transferred into wild-type recipient
mice. Subsequently, a local immune response was induced by
vaccination of hind leg skin of recipient mice with plasmid DNA
encoding the OVA257–264 epitope (Fig. 1 A; Bins et al., 2005;
Oosterhuis et al., 2012; Ahrends et al., 2016). Local vaccination
induced clonal expansion and subsequent contraction of the
barcode-labeled OT-I T cell pool (Fig. 1 B). At late time points
(>60 d) after vaccination, GFP+ OT-I T cells remained detectable
at low frequencies in both the circulation (Fig. 1 C, left) and at
the site of skin vaccination. Consistent with prior work, the
large majority of the barcode-labeled TRM harvested from the
tissue site expressed the canonical tissue-residency markers
CD69 and CD103 (Fig. 1 C, middle and right).
Having validated that skin vaccination induces clonal ex-
pansion of naive barcode-labeled T cells and their differentiation
into TEFF, TCIRCM, and TRM, we aimed to assess whether indi-
vidual naive T cells differ in their capacity to yield TEFF at dis-
tinct body sites. To this end, vaccinated recipient mice were
sacrificed at the peak of the TEFF expansion phase (day 12); blood,
spleen, draining lymph nodes, and affected skin tissue were
collected; and clonal output was quantified by DNA barcode
sequencing (Fig. 1 D, top). Barcode analysis of GFP+ OT-I T cells
present in the blood compartment at the peak of the response
showed that, similar to prior lineage-tracing studies involving
Listeria monocytogenes–OVA257–264 infection (Buchholz et al.,
2013; Gerlach et al., 2013), the capacity of individual naive
T cells to expand in response to DNA vaccination was highly
variable, with ∼7% of the clones producing ∼50% of the total
TEFF pool. Comparison of clonal output in the sampled tissue
sites showed that at the peak of the T cell response, the vast
majority of clones contributed to the TEFF pool at all four ex-
amined locations (Fig. 1, D and E; controls in Fig. S1, A and B).
Furthermore, the relative sizes of individual T cell clones at
these different sites were highly correlated (r > 0.8), indicating
that the progeny of different naive T cells possess a similar ca-
pacity to disseminate throughout the body during the TEFF phase
(Fig. 1 D). As a control, the high clonal overlap between T cell
compartments in skin and at other body sites was shown not to
be explained by a potential contamination of skin samples with
blood-borne T cells (Fig. S1 C). Thus, the ability to enter inflamed
peripheral tissues is equally distributed over the progeny of
responding naive T cell clones.
Clonal bias in TRM generation
Having established that individual T cell clones display a similar
capacity to disseminate to the skin and lymphoid compartments
during the effector phase, we next evaluated whether this equal
distribution of clones persisted into memory. To quantify the
output of individual clones in the two memory compartments,
recipient mice received a local skin vaccination, TEFF blood
samples were drawn on day 12, and the skin TRM and TCIRCM
populations from the same mice were isolated after memory
formation (day >60; Fig. 2 A). In line with prior work (Gaide
et al., 2015), comparison of clone sizes in the two memory pools
revealed that the vast majority of naive T cells contributed to
both the TCIRCM and TRM cell lineages (84.8%). Strikingly,
however, the contribution of individual T cell clones to the
TCIRCM or TRM pool was highly disparate (r = 0.32; Fig. 2 B,
quality controls in Fig. S2, A and B). Importantly, this low degree
of similarity was not due to suboptimal sampling, as shown by
the high correlation (r > 0.9; Fig. S2 A) of technical replicates of
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either the skin TRM or the TCIRCM pool. Thus, although during the
effector phase individual T cell clones contribute essentially
equally to the T cell pool at different body sites, many clones
preferentially contribute to either the TCIRCM or the TRM pool
after contraction. This disparity in memory clone distribution is
also present upon natural infection, as shown by DNA barcode
analysis of the TCIRCM and TRM compartments after localized
HSV-OVA257–264 infection (r = 0.25; Fig. 2 C). Specifically, after
HSV-OVA257–264 infection, the average T cell clone preferentially
contributed to either the TRM or the TCIRCM compartment by a
factor of 11.34-fold (mean ratio of contributions to the two
memory compartments, taking the lowest contribution as
denominator and excluding nonshared clones). As a control, the
average ratio between technical replicates was 2.19 (r = 0.86). By
the same token, in response to DNA vaccination, T cell clones
showed a preferential contribution toward either the circulating
or skin-resident memory T cell compartment by a factor of 11.98
(factor of 1.66 between technical replicates).
Next, we examined whether the bias in TRM and TCIRCM
generation in response to DNA vaccination could be explained
by differences in clonal TEFF expansion. First, to exclude clones
that could show clonal bias because of random sampling varia-
tion, clones that were exclusively observed in one of the two
memory T cell compartments and that represented <0.25% of
Figure 1. Proportional contribution of individual T cell clones to the systemic and skin effector response. OT-I thymocytes were transduced with the
barcode library and intrathymically transferred into recipient mice. After maturation, barcode-labeled GFP+ OT-I T cells were transferred into secondary
recipients that were subsequently exposed to skin vaccination. (A) Schematic overview of experimental setup. (B) Barcode-labeled GFP+ OT-I T cell response
to DNA vaccination, measured in blood (n = 11 mice, gray lines). Black line represents group average. (C) Representative flow cytometry plots showing the
presence of GFP+ memory T cells within CD8+ cells in blood and skin >60 d after vaccination. (D and E) Spleen, skin, draining LNs, and whole blood were
collected from vaccinated recipient mice 12 d after start of vaccination. (D) Analysis of the contribution of individual T cell clones to the spleen, blood, and
draining LN effector stage T cell compartment, relative to the skin effector–stage T cell compartment. Spearman correlation r was calculated over clones
detected in both samples. Left: Spearman correlations for individual mice (n = 4), mean with whiskers representing SD. Right: Dots represent individual clones;
P values were <0.0005. (E) Clonal output in all examined tissues of the 5% of largest clones detected in skin tissue. Heat map depicts log10-transformed clone
sizes (read counts). D and E are representative data of two independent experiments.
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that pool were removed (retaining 58.5% of barcodes and 97.2%
of reads; before filtering, Fig. 2 B; after filtering, Fig. 2 D; fil-
tering strategy, Fig. S2 C). Subsequently, to be able to identify
biased clones, we defined a “bias threshold” based on compari-
son of technical replicates, a setting in which clonal bias can by
definition not occur (Fig. S2 C). Application of the resulting
threshold (fold difference of >4.8) to the lineage-tracing data
revealed that close to 50% of T cell clones preferentially con-
tributed to either memory T cell compartment, with 29.7% of
clones being biased toward TRM formation and 16.9% toward
TCIRCM formation (Fig. 2 D). Notably, analysis of effector phase
burst sizes of TRM-biased, TCIRCM-biased, and nonbiased T cell
clones showed that biased memory cell generation was also
observed for TEFF-stage clones that had undergone massive or
little expansion (Fig. 2, E and F). These results demonstrate that,
independently of clonal burst size, a large fraction of T cell
clones preferentially produces TRM or TCIRCM, indicating that
TRM and TCIRCM are separated not only by location and pheno-
type but also by descent.
Nonstochastic formation of tissue-resident and systemic T cell
memory
Next, we wanted to understand whether the clonal bias ob-
served in memory (Fig. 2, B and D) was due to remodeling of
either the circulatory or the skin-resident compartment during
T cell contraction. As clonal hierarchy is highly similar at dif-
ferent body sites during the effector phase (Fig. 1, D and E), we
reasoned that the TEFF pool in blood could be used as a “historical
snapshot” of clonal distribution in all immune compartments
before memory formation. Comparison of clone sizes of day-12
effector blood to the skin and spleen compartment in effector
and memory phase demonstrated that both compartments in
memory phase were substantially more disparate from TEFF
blood than during effector phase (Fig. 3, A–C; and Fig. S3). Thus,
during memory formation, both the skin-resident and the cir-
culating T cell compartment undergo a substantial change in
clonal hierarchy (Fig. 3, A–C; and Fig. S3), resulting in differ-
ential contributions of individual T cell clones to the two
memory compartments (Fig. 2 D).
The observed divergence in clonal composition of T cell
populations at the two sites could arise either through an in-
trinsic difference in cell fitness to survive in particular micro-
environments or through the stochastic engraftment of cells at
the individual sites. To test the latter hypothesis, we simulated
the generation of TRM and TCIRCM pools that were derived from a
founder population with a size that equaled either the experi-
mentally observed T memory pool (indicated as α; Fig. 3 D), 10%
of the observed T memory pool, or the smallest possible founder
pool (i.e., the number of individual clones observed in the
memory pool, indicated as β; Fig. 3 D). Subsequently, the cor-
relation in clone sizes between the simulated T memory pools
and the experimentally observed TEFF pool (indicated as Y;
Fig. 3 D) were calculated and compared with the correlation
between the experimentally observed T memory and TEFF pool
(indicated as X; Fig. 3 D). Note that only when Y approaches X,
stochastic engraftment of T cells can explain the observed clonal
bias in memory phase. Interestingly, this analysis demonstrated
that stochastic engraftment of a founder population with the size
of the observed Tmemory pool (α) or one tenth of this size could
not explain the observed skewing during T memory formation
in any of the mice (Fig. 3 E). Furthermore, stochastic engraft-
ment by the smallest possible founder pool was also insufficient
to explain the skewing in the observed T cell memory pool in the
majority of mice (Fig. 3 E). Collectively, these data indicate that
Figure 2. Clonal bias in TRM generation. (A)
Representation of experimental timeline.
Barcode-labeled TRM and TCIRCM were isolated
from the skin and circulatory compartment
(spleen, LN, and blood) of DNA-vaccinated mice
(or HSV-OVA257–264–infected mice; C), and clo-
nal output was quantified. (B) Comparison of
clonal contribution to the skin TRM and TCIRCM
compartment after DNA vaccination. (C) Com-
parison of clonal contribution to the skin TRM
and TCIRCM compartment after HSV-OVA257–264
infection. (D) Clones responding to DNA vacci-
nation were defined as TRM biased, TCIRCM bi-
ased, or nonbiased, based on their relative
contribution to either memory compartment.
Scatterplot similar to B highlighting TRM-biased
(blue), TCIRCM-biased (red), and nonbiased (gray)
T cell clones. Small clones for which clone size
measurements were less reliable were excluded
from analysis and are not depicted. (E and
F) Comparison of effector stage burst size of
nonbiased (gray), TRM-biased (blue), and TCIRCM-
biased (red) T cell clones. In E, values on y axis
depict (clone size TRM − clone size TCIRCM)/
(clone size TRM + clone size TCIRCM) and represent the degree of preferential contribution to TRM or TCIRCM. Dashed lines indicate bias threshold of 4.8-fold. In
F, median with whiskers representing minimum/maximum, Kruskal–Wallis test with Dunn’s multiple comparisons test; N.S., not significant. In B and C,
Spearman correlation r was calculated over all clones that contributed to both samples, P < 0.0005 (B) and P = 0.01 (C). Dots represent individual clones.
Data from four mice, representative of two individual experiments.
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the skewed composition of both the TRM and the TCIRCM pool is
unlikely to be explained by stochastic survival or engraftment,
thereby suggesting the existence of intrinsic differences be-
tween T cell clones in their capacity to form systemic and tissue-
resident T cell memory.
The circulating TEFF pool harbors cells with a TRM-like
transcriptional signature
The pool of circulating TEFF is phenotypically and transcrip-
tionally diverse and, next to the commonly recognized subsets of
terminal effector (TE) cells and memory precursor (MP) cells,
additional heterogeneity has been reported (Gerlach et al., 2016;
Arsenio et al., 2014). To understand whether such heterogeneity
could explain preferential TRM formation by individual T cell
clones, we performed scRNA-seq on blood-derived barcode-
labeled TEFF (day 12) and subsequently determined clonal out-
put in the TRM and TCIRCM populations of the same mice at day
>60. Importantly, as barcode sequences are contained within the
39 untranslated region of GFP transcripts, scRNA-seq allowed for
the parallel analysis of transcriptional state and clonal origin of
individual vaccine-specific TEFF (see experimental setup in
Fig. 4 A).
To delineate the transcriptional heterogeneity within the
pool of sequenced TEFF, the MetaCell (MC) algorithm (Baran
Figure 3. Nonstochastic formation of tissue-resident and systemic T cell memory. (A) Contribution of T cell clones to the TRM (left) or TCIRCM (right) pool,
relative to the effector stage blood compartment. Spearman correlation r was calculated over T cell clones that were detected in both samples; n = 4 mice.
(B) Spearman correlations of clone sizes in skin (left) and spleen (right) samples collected during effector (n = 4 mice) and memory (n = 4 mice) phase to day-12
effector blood. (C) Clone size disparity of skin (left) and spleen (right) T cell pools in the effector and memory phase from the day-12 effector blood T cell pool.
See Fig. S3 A for the definition of disparity. (D) Illustration depicting the strategy used to assess whether stochasticity can explain the observed clonal skewing
during memory formation. Based on observed clone distribution in the TEFF pool, a virtual pool of TEFF cells is generated in silico, from which cells are sampled
to form a randomly selected TRM or TCIRCM memory pool. The number of randomly sampled cells is equal to the number of observed cells in the biological
memory (TM) pool (α), to 10% of the observed TM pool (α/10), or to the number of observed clones in the biological TM pool (β), which represents the smallest
theoretically possible TM founder pool. The Spearman correlation coefficient between the randomly sampled cell pool and the experimentally observed TEFF
pool is calculated (Y) and compared with the Spearman correlation coefficient between the experimentally observed TM pools and the experimentally observed
TEFF pool (X). Only if Y approaches X, stochastic engraftment can explain the observed skewing in clonal output in the TM pool. (E) Stochastically formed TRM
(left) and TCIRCM (right) pools were modeled 10,000 times in silico, as described in D, and the Spearman correlation between the modeled memory pools and
the observed TEFF pool was calculated (Y). Graphs indicate individual mice (n = 4); histograms represent the distribution of Spearman r. Red vertical line
indicates the correlation between the clonal distribution of the TEFF pool and the experimentally observed memory pool (X). Spearman correlations r were
calculated over all clones detected in either the effector pool or the (modeled or experimental) memory pool. In A, dots represent output of individual clones. In
B and C, dots represent individual mice. Spearman correlation r was calculated over clones that were detected in both samples: P < 0.0005 (A, left) and P <
0.0005 (A, right); Mann–Whitney U test, *, P < 0.05 (C). Representative data of two independent experiments.
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et al., 2019) was applied, resulting in the grouping of 5,383
T cells into 14 reproducibly detected MCs (Fig. 4 B and Fig. S4, A
and B). Expression analysis of Ilr7a and Klrg1 (genes commonly
used to identify the MP and TE populations, respectively)
demonstrated substantial variation in expression over the MCs,
underlining the variability in cell states within the TEFF pool.
Next, to distinguish MCs that correspond to TE and MP TEFF cell
states, expression of a multitude of genes associated with MP
(Sell, Cd28, Il7r, Cd27, and Cxcr3) and TE (Klf2, Tbx21, Cx3cr1, Klrg1,
and Zeb2; Chen et al., 2018) were analyzed at the MC level. Hi-
erarchal clustering of MCs based on this gene set segregated the
14 MCs into three distinct classes: MP (7 MCs), TE (4 MCs), and
Figure 4. scRNA-seq reveals a transcriptional TRM-like MP state in the circulating TEFF pool. Barcode-labeled TEFF were isolated from blood of recipient
mice at day 12 after skin vaccination, and scRNA-seq was performed to map transcriptional profiles of circulating effector cells. In addition, barcode sequences
were specifically amplified from single cell–derived cDNA and subsequently sequenced (single-cell barcode sequencing). Matching of cellcode sequences
(sequences marking all transcripts derived from a single cell) in scRNA-seq and single-cell barcode sequencing datasets allows for the coupling of tran-
scriptional profile and clone of origin of individual TEFF cells. (A) Schematic overview of the experimental procedure. (B) Left: 2D projection of 5,383 TEFF cells
that, based on transcriptional profile, are grouped into 14 distinct MCs. MC colors indicate assigned TEFF state, as defined in C (red/brown, TCIRCM-like; blue,
TRM-like MP; purple, TE; gray, Int). Right: 2D projections with superimposed expression of Il7r and Klrg1. Legend indicates gene expression Z-score. (C) Left:
Hierarchical clustering of 14 transcriptionally distinct MCs based on the expression of TE- and MP-associated genes. Legend indicates log2 enrichment Z-score.
Right: Hierarchical clustering, based on the expression of core TRM and TCIRCM genes, of the seven MCs that are classified as MP. (D) Gene expression
comparison of genes associated with skin TRM biology between the four defined TEFF transcriptional states (i.e., TCIRCM-like, TRM-like MP, TE, and Int). Values on
axis represent log2 enrichment Z-score. Spearman correlation r, P < 0.005. In B–D, data were obtained from three mice.
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intermediate (Int; 3 MCs) T cells (Fig. 4 C, left). To subsequently
reveal possible heterogeneity within the seven MP MCs in ex-
pression of gene sets associated with TRM formation, we selected
genes that have previously been described as differentially ex-
pressed between mature skin TRM and TCIRCM (Table S1; Mackay
et al., 2013; Pan et al., 2017). Strikingly, clustering of theMPMCs
based on core TRM and TCIRCM genes separated the MP population
into two main clusters; one (three MCs) that displayed prominent
expression of TCIRCM-related genes, such as the lymphoid homing
markers Sell (CD62L) and Cxcr5, and also the transcription factors
Klf3 and Eomes; and a second cluster (four MCs) that was strongly
enriched for core TRM signature genes, such as Itgae (CD103), Itga1
(CD49a), and Fabp5 (Fig. 4 C, right; and Table S1). Based on this
enrichment and depletion of TRM- and TCIRCM-associated genes,
we classified these two MP clusters as TRM-like and TCIRCM-like
MPs. In summary, based on gene expression profiles, we divided
the high-complexity TEFF pool into four distinct transcriptional
states: TE, Int, TCIRCM-like MP, and TRM-like MP (Fig. S4 C).
To determine the resemblance of the TRM-like MP population
observed in blood to bona fide skin TRM in more detail, we also
evaluated expression of additional genes involved in TRM biology
that are not included in the previously used gene set. Notably,
genes encoding the surface molecule CD101 (Cd101; Kumar et al.,
2017) and the nuclear aryl hydrocarbon receptor AhR (Ahr; Zaid
et al., 2014), both considered signature skin TRM genes, were
pronouncedly expressed in TRM-like MP cells (Fig. 4 D). In ad-
dition, a strong relation between the expression of these genes
and Itgae (Cd101: r = 0.86, P < 0.0005; Ahr: r = 0.87, P < 0.0005)
was observed across all 14 MCs (Fig. 4 D). Furthermore, TRM-like
MP cells showedmarked expression of the skin-migratory genes
Ccr10 and Cxcr6 (Xia et al., 2014; Zaid et al., 2017) and displayed
moderate to high expression of the IL-15 (Il2rb) and TGFβ
(Tgfbr1) receptors, of which the ligands have been described to
be essential for skin TRM differentiation and maintenance
(Fig. 4 D; Mackay et al., 2015). Collectively, these data demon-
strate the existence of a group of cells that transcriptionally
mimic TRM, within the pool of circulating vaccine-specific TEFF.
T cell clones differ in their contribution to the TEFF states
Next, we set out to test whether individual T cell clones differed
in their contribution to the four TEFF states. To this end, mRNA-
derived barcode sequences were mapped to their associated
transcriptome by matching the cell code sequences that mark all
transcripts derived from an individual cell. For 28% of the TEFF
from which we had retrieved gene expression data (1,527 of the
5,383 cells), we could reliably determine barcode sequences, and
thus, infer clonal origin. These 1,527 cells were distributed over
151 clones, ranging from 1 to 189 sampled cells per clone, with a
mean andmedian count of 10 and 4 cells, respectively (Fig. S4 D).
Analysis of the distribution of clonally related cells over the four
effector subsets revealed that clones differed significantly in
their TEFF output toward the different T cell states, as indicated
by the deviation from the expected distribution in case of sto-
chastic TEFF differentiation (χ square test, P < 0.0005). For ex-
ample, while some clones almost exclusively produced TE
(i.e., ∼12% of TEFF-stage clones consisted of >80% TE, versus a
median of 37.5%), other clones were strongly skewed toward the
production of TRM-like MP (i.e., ∼5.5% of TEFF-stage clones
consisted of >70% of TRM-like MP, versus a median of 26.1%;
Fig. 5 A). To evaluate whether the adoption of transcriptional
biases in the TEFF pool could be driven by variations in clonal
expansion, we assessed the relation between TEFF clone size,
determined by bulk DNA barcode sequencing, and the relative
contribution of each clone to the different TEFF subsets. No direct
association between TEFF clone size and TEFF cell state was de-
tectable in response to skin vaccination, as TEFF subset bias was
observed for small and large clones (Fig. 5 B). Thus, clones re-
sponding to local skin vaccination differentially generate the
subpopulations that jointly make up the TEFF pool, and this bias
cannot be explained by level of clonal expansion.
TRM-like transcriptional signature in effector phase predicts
TRM-forming potential at the clonal level
The above data reveal the existence of a subgroup of circulating
TRM-like cells in the effector phase and demonstrate that
Figure 5. Differential contribution of antigen-specific T cell clones to
distinct TEFF states, independent of clone size. The relative contribution of
individual antigen-specific T cell clones to the four TEFF states was assessed.
(A) Heat map depicting the contribution of 91 clones to the 4 identified TEFF
states. The sum of each row equals 100%. (B) Comparison of the relative
contribution to a transcriptional state (i.e., TCIRCM-like, TRM-like MP, TE, or Int)
and clone size in day-12 effector blood. Spearman correlation P values are
depicted. Dots represent individual clones. Red line represents the linear
regression line. Note that biased output toward the four TEFF states is ob-
served for both small and large clones and is not explained by stochasticity.
Data obtained from three mice.
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individual clones vary in their contribution to this subgroup of
effector-phase T cells. To determine whether the observed TRM-
like cells could be considered circulating TRM precursors, we
analyzed the relationship between skin TRM clone size 75 d after
vaccination and transcriptional state of the matched clone in
the circulating effector phase compartment 12 d after vacci-
nation. Notably, relative output of individual T cell clones to the
TRM-like MP pool in the effector phase showed a significant
correlation with TRM clone size in skin during memory,
whereas such a correlation was not observed for the three other
TEFF states (Fig. 6 A). To further understand the relationship
between contribution to the skin TRM pool and TEFF states, we
selected clones either randomly (n = 15, 10,000×) or with a
proportional bias toward clones that dominated the skin TRM
pool (i.e., in case clone A generated 2× more TRM than clone B;
clone A was 2× more likely to be selected than clone B), or with
a proportional bias toward small TRM clones (i.e., in case clone
A generated 2× more TRM than clone B; clone A was 2× less
likely to be selected than clone B). Analysis of mean TEFF state
output by large (Fig. 6 B, red histogram) and by small (Fig. 6 B,
blue histogram) TRM clones demonstrated that the propensity
of clones to form TRM is predicted by the production of TRM-like
MP by such clones in the effector phase. In contrast, production
of TCIRCM-like MP during the effector phase was not predictive
of TRM formation capacity. As a control, a similar analysis of the
TCIRCM pool revealed that TCIRCM formation was predicted by
the production of TCIRCM-likeMP, but not TRM-likeMP (Fig. 6 B,
bottom), and this observation was corroborated by correlation
analysis (Fig. S4 E). In line with expectations, a skewing of clonal
output toward the TE state during the effector phase was asso-
ciated with a diminished capacity to yield both TRM and TCIRCM
(Fig. S4 F). Additional analysis of the relationship between TRM
formation and the absolute quantities of circulating TRM-like and
TCIRCM-like MPs produced by individual clones during the ef-
fector phase furthermore suggested that total TRM-like MP pro-
duction better predicts mature TRM formation at the clonal level
(R2 = 0.37, P < 0.0005; and r = 0.59, P < 0.0005), than the
quantities of TCIRCM-likeMP (R2 = 0.20, P = 0.012; and r = 0.47, P =
0.01; Fig. S4 G). Jointly, these data demonstrate that T cell clones
that preferentially yield circulating TRM-like MP cells in the ef-
fector phase are endowed with a superior TRM forming capacity.
To test whether skewing toward TRM-like MP during the
effector phase could explain not only TRM clone size in memory
but also the preferential production of TRM over TCIRCM, as de-
scribed in Fig. 2 D, clones with various degrees of memory bias
(i.e., ratio clone size in TRM pool/clone size in TCIRCM pool) were
selected in silico (Fig. 6 C, bottom), and relative production of
TRM-like and TCIRCM-like MP by these clones during the effector
phase was analyzed. Notably, production of TRM-like MP cells
during the effector phase was positively associated with the
subsequent preferential production of TRM over TCIRCM (Fig. 6
C). Moreover, gene-expression analysis of the 10 most TRM-
biased and 10most TCIRCM-biased clones demonstrated that TEFF-
stage clones that preferentially produce TRM express elevated
levels of core TRM genes, while being depleted of core TCIRCM
genes (Fig. 6 D). In conclusion, the nonstochastic capacity of
clones to preferentially form TRM is preceded by the acquisition
of a TRM-fate poised transcriptional profile by these clones in the
circulating TEFF compartment.
TRM differentiation is a clone-imprinted attribute that is
preserved upon secondary antigen encounter
Based on the observed relationship between the capacity of
clones to form TRM and the transcriptional profile of these clones
during the effector phase, we hypothesized that the circulating
TEFF pool harbors cells that are already committed to the TRM
fate. If TRM fate decisions are indeed made before entry of the
inflamed tissue site, a pool of responding T cell clones would be
expected to reproducibly show the same TRM-forming capacity
at different immunized skin sites. To test this, we generated two
anatomically separated pools of skin TRM, by parallel vaccination
of the right and left hind leg skin of mice (Fig. 7 A). If the de-
velopment of TRM would be determined solely by stochastic
encounter of inflamed skin-derived microenvironmental sig-
nals, clone size distributions in the two anatomically separate
skin sites would be expected to be disparate. Conversely, if TRM
fate commitment were to be imprinted in circulating TEFF-stage
clones, the two skin sites would be expected to show a similar
clonal distribution. Comparison of the clonal composition of
either the left or the right leg skin TRM compartment with that of
the TCIRCM compartment at day >60 after vaccination recapitu-
lated the prior observation that a large fraction of naive T cells
yield progeny that either preferentially form TRM or TCIRCM
(TRM-LEFT − TCIRCM: r = 0.37, P < 0.0005; TRM-RIGHT − TCIRCM: r =
0.30, P < 0.0005), with the average T cell clone differing >10-
fold in contribution to the skin and the systemic memory com-
partment (average ratio TRM-LEFT − TCIRCM: 10.14, average ratio
TRM-RIGHT − TCIRCM: 11.67, Fig. 7, B and C). Strikingly, comparison
of the TRM populations at the two spatially separated skin sites
revealed a substantially higher degree of similarity (r = 0.78, P <
0.0005), with an average clone size ratio of 3.17 (Fig. 7, B and C).
To compare the magnitude of this clone-intrinsic bias in TRM
formation relative to a bias of individual T cell clones to yield
either systemic central memory (TCM) or effector memory (TEM)
T cells, we subsequently performed barcode lineage tracing of
TRM from the two anatomically separate skin compartments, of
TCM (defined as CD62L+) from LN and spleen, and of TEM (de-
fined as CD62L–) from spleen. Complete-linkage clustering
analysis again showed the highly similar clonal composition of
the memory T cells at the two spatially separated skin com-
partments (Fig. 7 D). In addition, this analysis revealed that these
two TRM compartments differ more strongly in clonal compo-
sition from all the three systemic memory T cell compartments
than, for instance, splenic TEM and LN TCM differ from each
other (Fig. 7 D). Thus, relative to differences in capacity to
produce central memory or effector memory T cells, clonal
imprinting of the capacity to yield tissue-resident T cell memory
versus systemic T cell memory is profound.
Finally, to test whether the acquisition of TRM generation
potential is a stable property of CD8+ T cells, recipients of
barcode-labeled naive OT-I T cells were subjected to a primary
vaccination on the right hind leg, followed by a secondary vac-
cination on the left hind leg >60 d later (Fig. 7 E, top). In linewith
prior work (Casey et al., 2012; Jiang et al., 2012), low frequencies
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(on average fourfold less than at the vaccinated site) of TRMwere
detected at the initially unperturbed tissue site upon primary
vaccination (Fig. S5 A). Following secondary vaccination at this
site, local memory T cell numbers increased to exceed those seen
at the primary vaccination site, indicative of de novo TRM for-
mation induced by the secondary vaccine (Fig. S5 B). Subse-
quently, barcode abundance was separately assessed at the
primary and secondary vaccination site >60 d after secondary
Figure 6. Skewed production of circulating TRM-likeMP cells by T cell clones in TEFF phase is associated with enhanced TRM generation. Clonal output
in the TRM and TCIRCM compartments was assessed and compared with the transcriptional profiles of matched clones in the circulating TEFF compartment.
(A) Comparison of TRM clone size in memory with the relative output of individual clones to the distinct transcriptional TEFF states (i.e., TCIRCM-like, TRM-likeMP,
TE, or Int) during the effector phase. Spearman correlation r (when significant) and Spearman correlation P value are depicted. Dots represent individual clones.
Clones that were not detected in the TRM compartment were excluded. Red line represents the linear regression line. (B) Top: Analysis of relative production of
TCIRCM-like and TRM-like MPs during the effector phase by either large or small TRM clones in memory phase. 15 clones (of a total of 49) were randomly selected
10,000 times (gray histogram, middle), selected with a bias toward large TRM clones (red histogram, front), or selected with a bias toward small TRM clones
(blue histogram, back). The distribution of mean TCIRCM-like and TRM-like MP production of the sampled clones is plotted. Dotted line represents the most
frequently observed mean production of randomly selected clones. Bottom: Similar analysis as in top, but performed for large and small TCIRCM clones, using
random sampling of 69 clones. (C) Comparison of bias in memory generation of individual clones to their production of TCIRCM-like and TRM-like MP cells in the
effector phase. Clones that contributed to both the TRM and TCIRCM pool (n = 40) were selected according to their bias in memory production: 10 clones per
selection window, moving five clones with each step in the direction of TCIRCM-biased clones, depicted as red dots in scatterplots. The first selection window
represents clones with the most prominent bias to TRM generation; the last selection window represents clones with the most prominent bias toward TCIRCM
generation. Mean production of TRM-like (left) and TCIRCM-like MP (right) is plotted per window. Red lines represent smoothing spline curves. (D) Difference in
expression of core TRM (top) and TCIRCM (bottom) genes between the most TRM-biased TEFF-stage clones (n = 10) and most TCIRCM-biased TEFF-stage clones (n =
10). X axis represents log2 fold difference of mean expression of TRM-biased clones over TCIRCM-biased clones (fold difference calculated as mean expression
TRM-biased clones/mean expression TCIRCM-biased clones). Blue and red numbers indicate the sum of the log2 fold differences of genes enriched in TCIRCM- (red)
or TRM- (blue) biased clones. Data obtained from three mice.
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vaccination, and was compared with clone abundance in the
TCIRCM pool at the same time point. This analysis revealed that
the secondary TRM pool was dissimilar to the TCIRCM compart-
ment in terms of clonal hierarchy (average r = 0.5), but greatly
resembled the TRM pool generated at the primary site of vacci-
nation (average r = 0.73; Fig. 7 E). Furthermore, disparity
analysis (Fig. 7 F; explained in Fig. S3 A) revealed that the clonal
composition of these two TRM pools that were separated in time
Figure 7. TRM generation capacity is a clone-imprinted attribute that is preserved upon secondary antigen encounter. (A) Schematic timeline used in
B–D. (B) Contribution of T cell clones to the TRM pool present at two separate sites of primary vaccination (TRM-LEFT, TRM-RIGHT) relative to the TCIRCM pool (left)
and relative to each other (right). Dots represent individual clones. (A) Spearman correlations (left) and ratios (right) of nine individual mice, comparing the
clonal composition of the TRM-LEFT compartment to the TCIRCM and to the TRM-RIGHT compartment. Left: Mean with whiskers representing SD. Right: **, P <
0.005, Wilcoxon signed-ranked test. Data from nine mice from two independent experiments. (D) Output of individual OT-I T cells to different TRM and TCIRCM
pools, as indicated in the columns. Heat map depicts log10-transformed clone sizes (read counts), clustered using Euclidian distance. Data from six mice from
two independent experiments. (E and F) Recipient mice were vaccinated on the right hind leg (primary site) and >60 d later on the left hind leg (secondary site),
and clonal composition at both sites was assessed >60 d after secondary vaccination. Top: Schematic time line used in E and F. Bottom left: Contribution of
T cell clones to the TRM-SEC pool relative to the TRM-PRIM pool. Dots represent individual clones. Bottom right: Spearman correlations of six individual mice, mean
with whiskers representing SD. (F) Disparity between TRM-LEFT and TCIRCM pool (red) and between the TRM-LEFT and TRM-right pool (cyan) in case of simul-
taneous or staggered vaccination. prim/prim, simultaneous vaccination; prim/sec, primary and secondary vaccination separated by >60 d. N.S., not significant;
*, P < 0.05; ***, P < 0.0005; Mann–Whitney U test. Mean with whiskers representing SD. See Fig. S3 A for the definition of disparity. Dots represent individual
mice. prim/prim and prim/sec groups each consisted of nine mice. Data from three independent experiments. (G) Illustration of proposed TRM differentiation
model. After priming in the skin-draining lymph node, naive T cells undergo clonal expansion and a selection of activated T cells commit to the TRM fate. During
the effector phase, these transcriptionally distinct TRM precursor cells migrate, along with non-TRM precursor cells, to the inflamed skin tissue. At the inflamed
site, TRM precursors display a heightened capacity to mature into long-term persisting TRM in response to tissue-derived external signals, such as TGFβ, IL-15,
and antigen. Note that formation of TRM precursor cells may occur early during clonal expansion, as depicted here, or may reflect heterogeneity in T cell
potential that already exists before priming.
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was equally similar as when two distinct TRM pools were gen-
erated simultaneously, indicating that the capacity of individual
T cell clones to yield TRM is stable over time. Thus, these data
reveal that, before skin entry, the ability of TEFF to form TRM is
differentially and permanently imprinted at a clonal level.
Discussion
The current data demonstrate that, while all naive T cells yield
progeny that disseminate equally well to inflamed skin and the
systemic lymphoid compartments, a subset of T cell clones yields
offspring with a heightened capacity to persist long-term in
peripheral tissues. The observation that tissue entry is equal
between progeny derived from distinct clones implies that the
selection of the TRM privileged clones is not driven by an en-
hanced capacity of a subset of circulating effector-stage clones to
migrate into the inflamed tissue. Rather, the propensity of
clones to generate TRM was linked to the transcriptional state of
their circulating TEFF offspring, and in particular the production
of MP cells that transcriptionally resemble skin TRM was asso-
ciated with superior TRM formation. The observed link between
transcriptional state during the effector phase and contribution
to the TRM compartment following memory formation provides
compelling evidence that the identified TEFF subgroup can be
considered circulating TRM precursors. Furthermore, the notion
of a committed TRM precursor pool in the circulation is also
supported by the observation that the clonal composition of TRM
pools that form at anatomically separate sites is highly similar,
indicating that the propensity to efficiently produce TRM is im-
printed into T cells in the circulatory compartment, before tissue
entry. Previous reports have suggested that TEFF cells that de-
velop into TRM enter the peripheral tissue early after immuni-
zation (Masopust et al., 2010; Milner et al., 2017). As the current
data demonstrate that TEFF commit to TRM fate before tissue
entry, fate decisions of circulating TRM precursors should then
also occur early after immunization. In line with this, we ob-
serve that the capacity to generate TRM is unequally distributed
over T cell clones, which implies that this property must be
instilled before substantial clonal expansion. Collectively, our
observations argue in favor of early stage TRM fate commitment
by a subset of circulating TEFF. Although TRM fate decisions are,
at least partially, made in the circulatory compartment, earlier
work has established that skin microenvironmental cues, such
as TGFβ, IL-15, and cognate antigen (Mackay et al., 2015;
Muschaweckh et al., 2016), are essential in driving TRM forma-
tion. Jointly, these observations argue in favor of a model in
which a subset of circulating TEFF transcriptionally diverge and
subsequently develop a heightened capacity to respond to local
cues, thereby selectively promoting the differentiation of their
progeny into long-term persisting TRM (Fig. 7 G).
Through the combination of lineage-tracing and single-cell
transcriptome analysis, we uncovered a transcriptional dichot-
omy within the pool of circulating MP TEFF cells that precedes
the divergence in TRM and TCIRCM formation at a clonal level;
however, the mechanisms that drive this dichotomy remain to
be elucidated. Several studies have shown a link between TCR
affinity and TRM generation potential (Frost et al., 2015; Fiege
et al., 2019; Wang et al., 2019; Maru et al., 2017) and it would be
of interest to determine whether variation in TCR affinity may
influence the capacity of individual T cell clones to yield circu-
lating TRM precursor cells. However, the current data indicate
that differential production of circulating TRM-like MP and TRM
generation potential can occur independently of variation in
TCR affinity, suggesting that other T cell internal and/or ex-
ternal factors are involved. Indeed, an extensive body of work
has demonstrated that external signals, such as cytokines and
ligands of costimulatory receptors at the T cell priming site, can
influence the production of functional memory T cells (Hendriks
et al., 2005; Parameswaran et al., 2005; Mousavi et al., 2008;
Scholer et al., 2008; Agarwal et al., 2009; Cui and Kaech, 2010;
Ahrends et al., 2017). In addition, cross-priming by Batf3+ cDC1s
(Iborra et al., 2016) and inhibition of mTOR activity (Araki et al.,
2009; Sowell et al., 2014) have opposing roles in promoting TRM
over TCIRCM fate commitment. Conceivably, differential expo-
sure of individual T cell clones to these cues during the priming
process forms the mechanistic basis for the observed formation
of circulating TRM precursors. Furthermore, steady-state heter-
ogeneity in naive T cell-intrinsic properties, such as develop-
mental origin (Smith et al., 2018), prior TGFβ exposure (Mani
et al., 2019), and stochastic variation in gene expression
(Feinerman et al., 2008; Marchingo et al., 2016), could differ-
entially precondition naive T cells for TRM fate. Evaluation of the
role of these T cell external and internal factors should be of
value to delineate the mechanistic processes that leads to the
generation of the circulating TRM precursor population that we
here identify.
Materials and methods
Mice
C57BL/6J-Ly5.1, C57BL/6J, OT-I, mTmG, and UCB-GFPmice were
obtained from Jackson Laboratory, and strains were maintained
in the animal department of the Netherlands Cancer Institute.
The mTmG and UCB-GFP mice were crossed with OT-I mice to
obtain mTmG-OT-I and GFP-OT-I strains, respectively. All ani-
mal experiments were approved by the Animal Welfare Com-
mittee of the Netherlands Cancer Institute, in accordance with
national guidelines.
Generation of the BC2.0 high-diversity retroviral barcode
library
The BC1DS_lib oligonucleotide (Table S2) containing a 21-nt
random barcode sequence was PCR amplified (10 cycles: 10 s
at 98°C, 30 s at 55°C, and 1 min at 72°C) with Phusion polymerase
(New England Biolabs). The resulting PCR-amplified product
was column purified (MinElute PCR cleanup kit; Qiagen) and
digested with XhoI and EcoRI, followed by ligation into the 39
untranslated region of the GFP cDNA sequence within the pMX
retroviral vector, using the Electroligase kit (New England Bio
labs). Electrocompetent DH10b bacteria (Invitrogen) were then
electroporated with 16-ng ligation product, and a small fraction
of the transformed bacteria were plated on Luria-Bertani agar
plates to determine transformation efficiency; the remaining
bacteria were grown overnight in 400 ml Luria-Bertani medium
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(VWR Life Science) supplemented with ampicillin (Sigma-
Aldrich). DNAwas extracted from the bacterial culture using the
Maxiprep kit (Invitrogen).
Establishment of the barcode reference list
To be able to match barcode sequences observed in biological
samples to a reference list of barcodes present in the BC2.0 li-
brary, barcode sequences in the library were PCR amplified in
duplicate (repA and repB) and sequenced as independent sam-
ples. In brief, barcodes were amplified from 10 ng of retroviral
library DNA using a combination of native Taq DNA polymerase
(Invitrogen) and Deep Vent polymerase (New England Biolabs)
at a 2:1 ratio, in three consecutive rounds of PCR. First-round
PCR was performed using the Top_lib and Bot_lib primers (15
cycles: 5 s at 94°C, 5 s at 57.2°C, and 10 s at 72°C); second-round
PCR was performed using the BC1v2DS_For and BC1v2DS_Rev
primers (15 cycles: 5 s at 95°C, 5 s at 58°C, and 10 s at 72°C); third-
round PCR was performed using the P5_For and P7_Index_Rev
primers (7 cycles: 5 s at 94°C, 10 s at 58°C, and 10 s at 72°C).
Resulting PCR products were sequenced on an Illumina hi-
Seq2500 lane. For primer sequences, see Table S2.
In the sequencing data of repA and repB, 349,439 and 333,422
unique barcode sequences were detected, respectively, with
64.32% of all detected sequences being shared between the two
replicates. Many of these sequences are likely to be spurious,
resulting from PCR and sequencing errors. Such spurious se-
quences derive from true “mother barcodes” that have a much
higher abundance than the “child” sequences, with child se-
quences differing by up to several nucleotides from the mother
sequence and having a reproducible frequency of occurrence of
up to ∼5% of the abundance of the mother barcode (Beltman
et al., 2016). To remove those spurious barcode variants, we
removed all sequences that had a Levenshtein distance of ≤4
nucleotides (Levenshtein, 1966) from a potential mother barcode
and that also had read count of ≤5% of that potential mother
barcode. Additional spurious barcodes that occur at a very low
abundance are likely to escape this cleaning procedure, for in-
stance because they contain >4 nucleotide differences from their
mother. For this reason, only barcodes that were detected
≥3 times in the two replicates combined were retained in the
barcode reference list. After this filtering, a list of 263,582
unique barcodes was obtained, of which only 1.27% was not
shared between technical replicates.
Generation of barcode-labeled T cells
Retrovirus of the barcode library was produced by transfection
of Phoenix-E packaging cells using FuGene6 (Roche). Retroviral
supernatant was harvested 48 h after transfection and stored at
−80°C. To generate naive barcode-labeled OT-I T cells, thymo-
cytes were harvested from 5–7-wk-old OT-I mice and trans-
duced with the barcode library virus by spinfection (90 min,
400 g) in IMDM (Gibco Life Technologies) supplemented with
8% FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, and 10 ng/
ml recombinant murine IL-7 (PeproTech). To limit the fraction
of T cells with multiple barcode integrations, barcode library
virus was diluted before transduction to obtain a transduction
efficiency of 8–10%. After 24 h of culture, cells were harvested,
and viable thymocytes were enriched using Lympholite-M Cell
Separation Medium (Cedarlane) followed by purification of
GFP+ cells by FACS (FACSAria II [BD Biosciences] and MoFLo
Astrios [Beckman Coulter]). Subsequently, ∼1 million sorted
GFP+ thymocytes were intrathymically injected into 5–7-wk-old
C57BL/6 or C57BL/6-Ly5.1 primary recipient mice, as described
previously (Gerlach et al., 2010; 2013). After a maturation period
of 2–4 wk, whole blood, spleen, and LNs (cervical, axillary,
brachial, mesenteric, inguinal, and lumbar) were harvested and
pooled, followed by enrichment of CD8+ T cells using the Mouse
CD8 T Lymphocyte Enrichment Set (BD Biosciences). The frac-
tion of GFP+ cells in the CD8+ T cell pool was determined by flow
cytometry (Fortessa; BD Biosciences), and 500–1,000 GFP+ cells
were adoptively transferred into 8–14-wk-old secondary C57BL/
6 or C57BL/6-Ly5.1 recipient mice.
Immunization by DNA vaccination and HSV1 infection
1 d before vaccination with the HELP-OVA vector that encodes
the OVA257–264 epitope (SIINFEKL), the shuffled HPV E7 se-
quence, and MHC-II class restricted helper epitopes (Oosterhuis
et al., 2012; Ahrends et al., 2016), fur was removed from hind
legs with Veet depilation cream (Reckitt Benckiser). Primary
DNA vaccination was performed on days 0, 3, and 6 by tattooing
(Bins et al., 2005) a 15-μl droplet of 2 μg/μl DNA solution in 10
mmol/l Tris, pH 8.0, and 1 mmol/l EDTA, pH 8.0, per leg, by
means of a sterile disposable 9-needle bar mounted on a rotary
tattoo device oscillating at a frequency of 100 Hz for 1 min with a
needle depth of 1 mm (MT.DERM). For secondary vaccinations,
mice received a single DNA tattoo with 20 μl of the 2 μg/μl
plasmid solution on the inside and outside of the leg, >60 d after
start of primary vaccination.
The HSVTOM-OVA virus, containing a CMV immediate-early
promoter tomato-OVA257–264 gene cassette in the intergenic re-
gion between the UL26 and UL27 genes of the HSV-1 strain KOS
(Halford et al., 2004), was grown in Vero cells, as described
previously (Weeks et al., 2000). 1 d before infection, fur was
removed from hind legs with Veet depilation cream (Reckitt
Benckiser). On day 0, a 7-μl droplet containing ∼3.125 × 105 PFU
HSVTOM-OVA in DMEM (Gibco Life Technologies) per area was
given once to both legs of anesthetizedmice bymeans of a tattoo,
using a sterile disposable nine-needle bar mounted on a rotary
tattoo device oscillating at a frequency of 100 Hz for 1 min with a
needle depth of 0.5 mm (MT.DERM). The first macroscopic skin
lesions became visible on treated areas on approximately day 3
after infection (not depicted).
Recovery of barcode-labeled T cells from vaccinated and HSV-
infected recipient mice
To sample the TEFF pool without sacrificing the animal, a 300-μl
blood sample was drawn from the tail vein. Erythrocytes were
lysed using NH4Cl, and samples were stored as cell pellets at
−80°C. To recover GFP+ T cells from skin and secondary lym-
phoid organs, in either the effector or memory phase, mice were
sacrificed, whole blood was collected by heart puncture, and
spleen and LNs (cervical, axillary, brachial, mesenteric, inguinal,
and lumbar) were harvested. Blood, spleen, and LN samples
derived from one mouse were processed as one sample, unless
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indicated otherwise. In addition, skin tissue from the hind legs
was collected and processed separately. For isolation of barcode-
labeled cells from skin tissue, Veet-depilated (Reckitt Benckiser)
full-thickness skin was collected using scissors and forceps and
minced into small pieces. Subsequently, skin fragments were
taken up in DMEM (Gibco Life Technologies) supplemented
with collagenase IV (Gibco) and II (Worthington Biochemical
Corp.; both 1.25 mg/ml final), DNase type I (0.25 mg/ml final;
Sigma-Aldrich), 4% FCS (Sigma-Aldrich), 0.25% BSA fraction IV
(Thermo Fisher Scientific), and HBSS (Gibco Life Technologies)
and rotated at 37°C overnight. After digestion, skin preparations
were diluted with DMEM containing 8% FCS, filtered over 100-
and 70-μm strainers (Falcon), washed twice, and taken up in
HBSS supplemented with 0.5% BSA, pulmozyme (40 μg/ml
final; Roche), and the indicated antibodies (Table S3). After
staining for 30 min at 4°C, samples were washed and filtered
through a 30-μm strainer (Miltenyi Biotec). To exclude dead
cells, samples were stained with DAPI (Sigma-Aldrich). Barcode-
labeled CD69+CD103+ skin-resident CD8+ memory T cells were
sorted on a FACSAria II (BD Biosciences) or FACSAria Fusion (BD
Biosciences). Typical yields were 1,000–10,000 GFP+ CD8+ cells
per leg.
Harvested spleen and LN tissue of individual mice was
mashed through a 70-μm strainer into single-cell suspensions
and pooled with matched blood samples. This pooled cell pool,
referred to as the circulatory compartment, was treated with
NH4Cl to remove erythrocytes and stained with the indicated
antibodies (Table S2). GFP+ CD8+ cells were then isolated by cell
sorting on a MoFLo Astrios (Beckman Coulter), with typical
yields of 1,000–10,000 GFP+ CD8+ cells per mouse. After isola-
tion, sorted cells derived from either the skin or circulatory
compartment were lysed in DirectPCR Lysis Reagent (Viagen
Biotech) supplemented with 0.4 mg/ml Proteinase K (Sigma-
Aldrich), and resulting samples were stored at −20°C.
Analysis of the presence of blood-borne T cells in the skin
TEFF pool
To determine the fraction of blood-borne T cells in skin prepa-
rations of the vaccination site obtained during the effector
phase, splenocytes of GFP-OT-I transgenic mice were first neg-
atively enriched with theMouse CD8 T Lymphocyte Enrichment
Set (BD Biosciences). Subsequently, C57BL/6J-Ly5.1 animals re-
ceived ∼700 naive GFP-OT-I splenocytes i.v., followed by pri-
mary DNA vaccination on Veet-depilated hind legs as described
above. On day 10 after vaccination, mice received a one-time
injection of 1.5 × 106 CD8+ negatively enriched mTmG-OT-I
splenocytes as a reference for blood-borne T cells, 5 min before
sacrificing the animals. Subsequently, blood and skin tissue was
harvested, and cells were isolated from the two compartments,
as described above. Single-cell suspensions were then stained
with IR-dye (Thermo Fisher Scientific) and analyzed on an LSR
II SORP (BD Biosciences).
Barcode DNA amplification and next-generation sequencing
Genomic DNA was isolated from frozen pellets of effector blood
samples using DNeasy Blood and Tissue (Qiagen) for down-
stream PCR. Sorted samples of lymphoid tissues and from skin
were lysed in DirectPCR Lysis Reagent (Viagen Biotech). Prod-
ucts of samples in experiments in which all samples contained
more than ∼3,000 barcode-labeled T cells were used for PCR
amplification without intermediate steps. To enhance barcode
recovery in experiments with samples with a lower GFP+ cell
count, barcode sequences were first captured from the obtained
genomic DNA (gDNA) preparations, using biotinylated DNA
capture oligonucleotides that anneal either 59 or 39 of the bar-
code sequence in the GFP gDNA (for oligonucleotide sequences,
see Table S2). If at least one sample in an experiment contained
<3,000 GFP+ cells, all samples in that experiment (independent
of their GFP+ cell count) were subjected to the barcode gDNA
capture protocol, to avoid the possible generation of bias by this
procedure. In brief, gDNA was sheared on the ME220 Focused-
ultrasonicator (Covaris) under the following conditions: time, 20
s; peak power, 70; duty%, 20; cycles/burst, 1,000. Next, sheared
gDNA was denatured and mixed 1:1 with hybridization buffer
(1 ml composition: 667.6 μl of 20× SSPE [Gibco]; 267.6 μl of 50×
Denhardt’s solution [Sigma-Aldrich]; 13.2 μl of 20% SDS [Sigma-
Aldrich]; 26.8 μl of 0.5 M EDTA, pH 8.0; and 26.8 μl water
supplemented with the biotinylated Capt_For_BClibv2 [50 fmol]
and Capt_Rev_BClibv2 [50 fmol] oligonucleotides). Hybridiza-
tion with biotinylated capture oligonucleotides was performed
overnight at 65°C. The next day, Streptavidin beads (Dynabeads
MyOne streptavidin T1; Invitrogen) were washed with 2× B&W
buffer (2 M NaCl in TE buffer, pH 8.0) in low-retention mi-
crotubes (Axygen) that were prerinsed with 400 ml of 10 mM
Tris, pH 8.0, solution, and the hybridized gDNAwas mixed with
the streptavidin beads for 30 min at room temperature. Subse-
quently, bead-bound gDNA was isolated by magnetic pulldown
using the Dynamag-2 magnet (Invitrogen). The isolated bio-
tinylated gDNA beads were sequentially washed once with
500 μl of 1× B&W buffer (diluted in TE buffer, pH 8.0), 200 μl of
0.5× B&W buffer (diluted in Tris buffer, pH 8.0), 200 μl of 0.25×
B&W buffer (diluted in Tris buffer, pH 8.0), and twice with
200 μl of 10 mM Tris buffer, pH 8.0. The bead-bound gDNAwas
directly used for downstream PCR amplification.
All samples were split into two separate technical replicates
before the first PCR amplification. Genomic barcodes were
amplified by nested PCRs using Taq polymerase (Invitrogen).
First, the barcode sequence was amplified using the Top_Lib and
Bot_Lib primers (30 cycles: 15 s at 95°C, 30 s at 57.2°C, and 30 s at
72°C). Subsequently, PCR products were subjected to a second
amplification (30 cycles: 15 s at 95°C, 30 s at 57.2°C, and 30 s at
72°C) using the BC1v2_DS_For and BC1v2_DS_Rev primers that
share the annealing sites of the Top_lib and Bot_lib primer, re-
spectively, but are tailed with sequences representing the Illu-
mina primer annealing sites. Finally, the resulting PCR products
were subjected to a third amplification (15 cycles: 15 s at 95°C,
30 s at 57.2°C, and 30 s at 72°C) using the P5_For and P7_
index_Rev primers that are tailed with the P5 or P7 adaptors,
respectively. The P7_index_Rev primer harbors a unique 7-bp
index sequence that allows multiplexed analysis of ≤144 samples
on one sequencing lane. The 7-bp indexes had a Levenshtein
distance of ≥3 bp from each other to avoid incorrect assignment
of reads due to PCR or sequence errors (Faircloth and Glenn,
2012). The final PCR products of individual samples were
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pooled, 322-bp fragments were purified using E-gel extraction
(Invitrogen), and PCR products were sequenced on a HiSeq2500
Illumina platform with a read length of 65 bp. For primer se-
quences, see Table S2.
Filtering of bulk lineage-tracing sequencing data
The reads obtained after sequencing were mapped to the bar-
code reference library, and reads that showed a 100% match to
the barcode constant region, an index sequence that corre-
sponded to one of the indices used during the PCR amplification,
and a full match to one of the 21-bp barcode sequences listed in
the reference library were retained. Using these filtering steps,
∼150–190 million reads (75–95% of total reads) were considered
of appropriate quality for downstream analysis.
To determine barcode sampling efficiency in biological samples,
reproducibility between technical replicates was analyzed, and
biological samples were excluded from further analysis when the
Spearman correlation coefficient between technical replicates was
<0.7. Next, barcodes that were not detected in both technical
replicates were excluded, removing on average 0.66% of the total
reads (and hence inferred cell fraction) per biological sample. After
removal of nonreproducibly detected barcodes, the normalized
read counts of the barcodes detected in the two technical replicates
were averaged. As an additional noise-filtering step, all barcodes
that represented <0.01% of reads per sample were excluded. Fi-
nally, read counts were renormalized to 10,000, yielding values
that represent relative T cell clone sizes in the biological samples.
Data filtering and downstream analysis were performed in R ver-
sion 3.6.0 (https://www.r-project.org/).
Bulk lineage-tracing data analysis after filtering
To allow the visualization of clones with a read count of 0 on a
log scale, read counts of all clones were plotted as read count + 1,
but original read count values were used for all calculations.
Correlations between samples were calculated over the barcodes
that were shared between the two compared samples, using
Spearman rank correlation. For data visualization, R (ggplot2
and pheatmap) and GraphPad Prism 7.03 were used.
All ratios were calculated as: Clone SizeSampleA/Clone
SizeSampleB, taking the inverse of this ratio if Clone SizeSampleA
was lower than Clone SizeSampleB, ensuring all outcomes were ≥1.
Nonshared barcodes were excluded from the ratio calculations.
To determine the clonal bias threshold described in Fig. 2 D,
technical replicate samples of all biological samples used in Fig. 2
were used, with barcodes having a normalized read count of
<0.5 excluded from the analysis. For all remaining barcodes, the
ratio in read counts between technical replicates A and B was
calculated, and a threshold was established such that 98% of
barcodes detected in all technical replicates would have a ratio
lower than this threshold (Fig. S2 C). This resulted in a clonal
bias threshold of 4.8, indicating that a clone had to contribute
≥4.8 times more to one of the normalized cell compartments
than to the other cell compartment to be considered biased.
Biased clones that were detected only in either the TCIRCM or TRM
compartment cannot be ascribed a read count ratio. To allow for
the visualization of these clones in Fig. 2 E, we applied the for-
mula (Clone SizeTRM − Clone SizeTCIRCM)/(Clone SizeTRM + Clone
SizeTCIRCM), resulting in values that range from −1 to 1, with
−1 being completely biased toward TCIRCM formation and 1 being
completely biased toward TRM formation.
To allow statistical analysis of the magnitude of clonal dis-
parity between different combinations of cell compartments, an
additional measurement of disparity was established (applied in
Figs. 3 C and 7 F). Specifically, to compare the magnitude of the
differences between sample A and two other samples (i.e., A−B
versus A–C), all barcodes observed in samples A, B, and C were
ranked in descending order based on the normalized read counts
observed in sample A (reference sample), taking along shared
and nonshared barcodes detected in the biological samples.
Next, the cumulative read count of the ordered barcodes in
sample A was plotted against the cumulative read counts in
sample A (providing a reference curve) and against the cumu-
lative read counts in samples B and C (Fig. S3 A). The level of
disparity was then determined by calculating the area between
the reference curve and the curves obtained for samples B and C.
In this analysis, a value of 0 signifies that samples are fully
identical with respect to clonal composition, and a value of 0.5
signifies a complete lack of overlap between samples.
Modeling stochastic survival of memory T cells
To model the composition of a memory T cell pool that is purely
formed by the stochastic survival of TEFF cells, random in silico
sampling of barcodes detected in the effector cell pool present in
peripheral blood was conducted (Fig. 3, D and E). Specifically, to
mimic stochastic memory formation, the probability of a clone
surviving was considered to be directly proportional to its rel-
ative contribution to the effector pool (i.e., if a clone represented
50% of the total TEFF pool, the probability of its offspring to be
sampled per draw would be 0.5). In silico modeling of the
memory pool of four mice was performed using the following
conditions: (1) by drawing a number of cells that was equal to the
number of experimentally observed TRM and TCIRCM cells; (2) by
drawing a number of cells that was equal to a fraction 0.1 of the
number of experimentally observed TRM and TCIRCM cells; and
(3) by drawing a number of cells that was equal to the number of
experimentally observed barcodes in the TRM and TCIRCM pool.
The first setting models a situation in which the memory com-
partment is derived from the effector compartment without any
further proliferation. The second setting models a situation in
which the memory compartment is formed by a combination of
cell death and expansion. The third scenario represents the most
extreme bottleneck scenario in which each barcode observed in
a memory compartment would be derived from a single cell that
survived after the effector phase. Notably, for the second and
third setting, we assumed that the final TRM pool is formed by
proliferation of the drawn founder pool, and that during this
expansion the hierarchy between founder clones does not alter.
For the three settings, samplingwas performed 1,000 times with
replacement. To measure the resemblance of the modeled
memory pool with the experimentally observed effector pool,
Spearman correlations were calculated over the relative sizes of
all clones and compared with the correlation between the ex-
perimentally observed effector pool and experimentally ob-
served memory pool.
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Single-cell barcode amplification from cDNA
From three vaccinated recipient mice, day-12 effector phase
blood (300 μl) was collected and subsequently stained with
fluorochrome-conjugated antibodies directed against CD8,
CD45.2, and Vβ5 (Table S3). In addition, each individual blood
sample was stained with distinct anti-mouse TotalSeq Hashtag
antibodies (TotalSeq-A0301, TotalSeq-A0302, TotalSeq-A0303;
BioLegend). After isolation of CD8+CD45.2+Vβ5+GFP+ cells
(considered barcode-labeled OT-I T cells) by FACS sorting on a
FACSAria Fusion (BD Biosciences), cells derived from the three
mice were mixed 1:1:1 and taken up in PBS supplemented with
0.04% BSA. Next, single-cell RNA isolation and cDNA generation
were performed according to the manufacturer’s protocol of the
10X Genomics Chromium Single Cell 39 kit. Before the frag-
mentation step described in the manufacturer’s protocol, 20% of
the amplified cDNA was taken out and used to specifically PCR
amplify barcode sequences. Primers for barcode amplification
were designed such that the cellcode and unique molecular
identifier (UMI) sequence are both preserved in the amplified
product. Barcodes were amplified using Q5 high-fidelity DNA
polymerase (New England Biolabs) in two consecutive amplifi-
cation rounds to make the product compatible with the Illumina
sequencing platform. First, the barcode sequence was amplified
using cDNA_r1_for and cDNA_r1_rev primers (Table S2); both
primers were tailed with the Illumina sequencing primer an-
nealing sites. Second, the resulting PCR products were amplified
using the cDNA_r2_for and cDNA_r2_rev primers to add the P5
and P7 adaptors to the products. Products were subsequently
sequenced on the Illumina MiSeq Micro platform. After se-
quencing, the transcripts with a read count of >4weremapped to
the barcode reference library, and transcripts that showed a
100% match to the barcode constant region and fully matched
one of the 21-bp barcode sequences listed in the reference library
were retained for downstream analysis.
scRNA-seq analysis
For analysis of single-cell transcriptomes, 25% of the single-cell
cDNA library, generated according to the manufacturer’s pro-
tocol of the 10X Genomics Chromium Single Cell 39 kit, was
sequenced on a NextSeq550 Sequencing System (Illumina), re-
sulting in the acquisition of a total of∼400million reads, and the
detection of 6,173 cells, with a median of 2,400 genes detected
per cell. Feature-barcode matrices were generated using the Cell
Ranger software of the 10X Genomics Chromium pipeline. Cells
that could be assigned to multiple mice or to no mouse (inferred
from the detection of multiple or no Hashtags), cells with a
transcript (UMI) count <2,000 or a mitochondrial gene fraction
>0.075 were excluded from downstream analysis. Furthermore,
cells that transcriptionally resembled B cells (n = 79, as deter-
mined by CD19 expression), erythrocytes (n = 11, as determined
by expression of Hbb-bs/Hba-a1/Hbb-bt/Hbba-a2), or throm-
bocytes (n = 96, as determined by Ppbp/Pf4 expression) were
excluded from the analysis. For further transcriptional profiling
of the remaining 5,383 cells, the Seurat (Butler et al., 2018) and
MC (Baran et al., 2019) algorithms were used.
Data from single-cell barcode sequencing and scRNAseq were
merged based on matching of cell code sequences, and bulk DNA
barcode sequencing data (of TEFF, TRM, and TCIRCM samples) was
combined with single-cell data by matching barcode sequences
to scRNA-derived barcode sequences. Clones were included for
downstream analysis when transcriptional profiles were deter-
mined of three or more cells and when clones were also detected
in the bulk DNA TEFF, TRM, or TCIRCM barcode sequencing data.
For analysis of differential expression of TRM- and TCIRCM-
associated genes in the circulating effector phase compartment,
as described in Fig. 6 D, the top 10 most TRM- and TCIRCM-biased
clones were selected, and mean gene expression per clone was
calculated. Next, the average mean expression of the 10 TRM- and
the 10 TCIRCM- biased clones was calculated for the core TRM and
TCIRCM genes (Table S1). To exclude lowly expressed genes that
are inherently prone to show more noise, only genes with a
mean expression level >0.1 normalized UMI count (calculated
over all individual clones) are depicted in Fig. 6 D.
Statistics
Statistical analyses were performed using the two-tailed Mann-
Whitney U test, Wilcoxon signed-rank test, Kruskal-Wallis test
with Dunn’s multiple comparisons test, and Spearman correla-
tion test, using R and GraphPad Prism 7.03. Results were re-
garded as statistically significant at a P value of <0.05, with *, P <
0.05; **, P < 0.005; and ***, P < 0.0005.
Data and code availability
Single-cell transcriptome data have been deposited in GEO un-
der accession no. GSE152282. All other source data and codes are
available upon reasonable request.
Online supplemental material
Fig. S1 shows quality controls of barcode quantification in skin
and circulation during the effector phase. Fig. S2 describes the
barcode filtering strategy and bias threshold determination. Fig.
S3 shows the contribution of T cell clones to the TRM and TCIRCM
pool in relation to their clonal burst size. Fig. S4 presents quality
controls of the scRNA-seq analysis and the relation between TEFF
subset production and memory generation potential of indi-
vidual clones. Fig. S5 demonstrates the occurrence of de novo
TRM generation upon secondary vaccination at previously un-
perturbed skin sites. Table S1 describes the core TRM and TCIRCM
genes depicted in Fig. 4 C. Table S2 describes the primer and
DNA-oligonucleotide sequences used to generate the barcode
library and to amplify barcode sequences from biological sam-
ples. Table S3 provides details on the fluorochrome-conjugated
antibodies used for flow-cytometric analysis.
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Supplemental material
Figure S1. Quality of barcode quantification and analysis of blood-borne T cell contamination in effector-phase skin samples. (A and B) Recipients of
barcode-labeled T cells were vaccinated, and whole blood and organs were harvested 12 d after first vaccination. (A) Measured clone sizes detected in
representative technical replicates of blood (left) and skin (right) samples. (B) Measured clone sizes detected in blood (left) and skin (right) of independent
mice. Dots represent individual clones. (C) Analysis of the presence of blood-borne T cells in skin preparations. Recipients of GFP+ OT-I T cells were DNA
vaccinated. 10 d after vaccination, mice received 1.5 × 106 Tomato+ OT-I T cells and were sacrificed 5min later. Top: Pie charts depicting the relative percentage
of GFP+ and Tomato+ cells in blood (left) and skin (right) preparations. Bottom: Representative flow cytometry plots. Cells are gated on live lymphocytes. Data
are representative of four mice.
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Figure S2. Quality control and analyses of the barcode-labeled TRM and TCIRCM compartment. (A) Measured clone sizes detected in technical replicates
of TRM (left) and TCIRCM (right) samples derived from the mice described in Fig. 2 B. Spearman correlation r was calculated over clones that were detected in
both technical replicates: P < 0.0005 (left); P < 0.0005 (right). (B)Measured clone sizes detected in TRM (left) and TCIRCM (right) of independent mice described
in Fig. 2 B. (C) Step-by-step description of the strategy used to filter biological data and define biased clones, as depicted in Fig. 2 D. First, unreliably detected
clones (indicated in red) are removed. Second, a bias threshold (dashed lines) is set, such that 98% of the clones in technical replicates fall below this threshold.
This threshold is subsequently applied to the biological data to identify clones with a bias in output that goes beyond the variation that occurs because of
technical noise. For the data presented in Fig. 2 B, the threshold identified only clones contributing >4.8 times to one sample than to the other to be considered
biased. Dots represent individual clones.
Kok et al. Journal of Experimental Medicine S2
The existence of a circulating CD8+ TRM precursor https://doi.org/10.1084/jem.20191711
D
ow
nloaded from
 http://rupress.org/jem
/article-pdf/217/10/e20191711/1047981/jem
_20191711.pdf by Leiden U
niv M
ed C
tr W
alaeus Library user on 03 Septem
ber 2020
Figure S3. Remodeling of the skin-resident and circulating memory compartment. (A) Example plots depicting the strategy to determine the disparity
between two cellular compartments, as applied in Figs. 3 C and 7 F. Disparity of compartments B and C to compartment A can be assessed by plotting the
fraction of cumulative reads of clones in compartments B and C, which are ordered based on their size (largest to smallest) in compartment A (y axis), to the
cumulative reads of the ordered clones in compartment A (x axis). Area between the compartment A reference curve and compartment B (left) and C (right)
curves is calculated to generate a measure of disparity. (B) Left: Illustration of the subdivision of ordered effector-stage T cell clones (large to small) into four
bins, with each bin containing 25% of all observed clones. Middle and right: Quantitative contribution of binned clones detected in effector blood to the TRM and
TCIRCM compartment. Median with whiskers representing minimum/maximum; ***, P < 0.0005, Mann–Whitney U test. (C) Relative contribution of TEFF clones
in bins 1–4 (highlighted in blue) to the TRM and TCIRCM compartments. In B and C, data are representative of two independent experiments; dots represent
individual clones.
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Figure S4. Transcriptional TEFF profile of T cell clones is linked to memory generation capacity. scRNA-seq and single-cell barcode sequencing were
performed on barcode-labeled TEFF cells responding to skin vaccination. The TEFF cells were grouped into 14 transcriptionally distinct MCs. (A) Relative
contribution of each mouse to the 14 MCs. (B) Number of cells assigned to each MC. Colors indicate the transcriptional TEFF subset individual MCs were
assigned to; see Fig. 4 C for the definition of the identified TEFF subsets. (C) Pie chart depicting the relative frequency of the four identified TEFF states.
(D) Number of TEFF cells observed for each reliably detected clone. (E) Comparison of TCIRCM clone size to the relative contribution of clones to the indicated
TEFF states (i.e., TCIRCM-like, TRM-like MP, TE, or Int). Spearman correlation r (when significant) and Spearman correlation P value are depicted. Dots represent
individual clones. Clones that were not detected in the TCIRCM compartment were excluded. Red line represents the linear regression line. (F) Analysis as
depicted in Fig. 6 B, but here depicting mean effector phase TE and Int output of large and small TCIRCM and TRM clones. (G) Comparison of the absolute
production of TRM-like MP (top) and TCIRCM-like MP (bottom) of clones to their production of mature TRM. Black line indicates linear regression line with 95%
confidence interval in gray.
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Three tables are provided online. Table S1 shows the core TRM and TCIRCM genes. Table S2 shows oligo-DNA and primer sequences
used to generate the barcode library and to PCR-amplify barcode sequences from biological samples. Table S3 lists the
fluorochrome-conjugated antibodies used for flow-cytometric analysis.
Figure S5. De novo TRM generation upon secondary vaccination in previously unperturbed sites. (A and B) Mice received GFP+ OT-I T cells (A) or
barcode-labeled OT-I T cells (B) and were subjected to DNA vaccination on the right hind leg, whereas the other hind leg remained unperturbed. (A) Analysis of
TRM frequencies in vaccinated (right leg) and nonvaccinated (left leg) skin sites >60 d after vaccination. (B) More than 60 d after primary vaccination, the
nonvaccinated (left leg) skin site was subjected to DNA vaccination. More than 60 d after secondary vaccination, the primary and secondary vaccinated skin
sites were harvested, and GFP+ TRM at the two sites were quantified. Number of barcode-labeled TRM detected at the primary and secondary skin vaccination
site of nine mice. *, P < 0.05, Wilcoxon signed-rank test. Dots represent individual mice.
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